asparaginase

Type: Keyphrase
Name: asparaginase
Publicerad Oct 23 2014 - uppdaterad Oct 24 2014 - 2 rapporter

Erytech Secures New Patent in the United States

Erytech reported the granting of a new patent in the field of asparaginase in the United States. According to a company release, the patent 'Test for predicting neutralization of asparaginase activity' (WO 2010/052315 A1) protects the process and methods ... [Published Individual.com - Oct 23 2014]
Publicerad Oct 23 2014 - uppdaterad Oct 23 2014 - 1 rapporter

Destructive Ulcerated Lesions of the Hard Palate

A 34-year-old woman presented with a 3-month history of ulcerated plaques on the palate and gingiva. Physical examination revealed two ulcerated lesions with irregular margins on the hard palate (Panel A) and gingival mucosa (Panel B). The palatal bone ... [Published New England Journal of Medicine - Oct 23 2014]
Publicerad Oct 23 2014 - uppdaterad Oct 23 2014 - 1 rapporter

NOVOZYMES A/S : Patent Issued for Method of Preparing a Heat-Treated Product

By a News Reporter-Staff News Editor at Life Science Weekly -- Novozymes A/S (Bagsvaerd, DK) has been issued patent number 8859023, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Novozymes A/S ).The patent's ... [Published 4 Traders - Oct 23 2014]
Publicerad Oct 21 2014 - uppdaterad Oct 21 2014 - 1 rapporter

Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014

Interested parties may access the live audio webcast via the Investors & Media section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time ... [Published Pettinga Financial Advisors - Oct 21 2014]
Publicerad Oct 20 2014 - uppdaterad Oct 21 2014 - 4 rapporter

ERYTECH PHARMA : wins EuropaBio’s Most Innovative European Biotech SME Award 2014

PRESS RELEASE ERYTECH wins EuropaBio's Most Innovative European Biotech SME Award 2014Lyon (France), October 9, 2014 - ERYTECH (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments ... [Published 4 Traders - Oct 21 2014]
Publicerad Oct 09 2014 - uppdaterad Oct 09 2014 - 1 rapporter

ERYTECH wins EuropaBio's Most Innovative European Biotech SME Award 2014

--Regulatory News:ERYTECH (Paris:ERYP)(Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, won EuropaBio's ... [Published Scottrade - Oct 09 2014]
Publicerad Oct 07 2014 - uppdaterad Oct 08 2014 - 1 rapporter

Test for predicting neutralization of asparaginase activity

Method of in vitro measurement of the presence of factors that are able to neutralize asparaginase activity in a sample of blood, plasma, serum or derived medium that may contain asparaginase neutralizing factors, obtained from a patient, comprising mixing ... [Published Free Patents Online - Oct 07 2014]
Publicerad Oct 02 2014 - uppdaterad Oct 02 2014 - 1 rapporter

Karolinska Development's CEO leaves, Erytech hits PhIII endpoints, VBL belatedly nails IPO

Welcome to the latest edition of our weekly EuroBiotech Report . The CEO of Karolinska Development ( STO:KDEV ) left the company--9 months after the CFO departed--and the board began a rethink of its strategy. VBL Therapeutics ( $VBLX ) made a belated ... [Published FierceBiotech - Oct 02 2014]
Publicerad Sep 30 2014 - uppdaterad Oct 01 2014 - 2 rapporter

Erytech reports positive Phase III results from Graspa study in acute lymphoblastic leukemia

French firm Erytech Pharma (Euronext: ERYP) and Italian drugmaker Recordati (RC: MI) have reported positive Phase III results from its study of Graspa in acute lymphoblastic leukemia.Compared to native L-asparaginase, Graspa gave statistically significant ... [Published Pharma Letter - Oct 01 2014]
Publicerad Sep 22 2014 - uppdaterad Sep 22 2014 - 1 rapporter

Understanding Digestive Enzymes

Enzyme ingredients step in to help provide a greater variety of safe and nutritious foods for consumers.By Claudia O’Donnell, Contributing EditorSep 22, 2014Quiz question: What do the dietary supplement Beano, Horizon Organic Lactose-Free milks, Shiloh ... [Published FoodProcessing.com - Sep 22 2014]
Entiteter: Lactase, Enzyme, Acrylamide
Publicerad Sep 15 2014 - uppdaterad Sep 15 2014 - 1 rapporter

Caring for a Child With Leukemia

at 9:14 am , by Kara CorridanWe continue to bring attention to month with another story from a parent who has been affected. (Last week we featured a post from Stefani Healey, the mother of Brooke, who died of a rare form of brain cancer last September.) ... [Published Parents.com - Sep 15 2014]
Publicerad Sep 15 2014 - uppdaterad Sep 15 2014 - 1 rapporter

ERYTECH Announces Second Positive DSMB Review of Its Phase IIb Study in Acute Myeloid Leukemia

By a News Reporter-Staff News Editor at Clinical Trials Week Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia ... [Published Pharmacy Choice - Sep 15 2014]

Citat

"The granting of this new patent in the United States is an additional tool to favor the future adoption of ERY-ASP/GRASPA by physicians. The test based on this patented technology will be developed in collaboration with a specialized industrial partner in view of making it available at the time of European Marketing Authorization, aimed by mid 2016" comments Pierre-Olivier Goineau, co-founder and COO of Erytech Pharma
From the background information supplied by the inventors, news correspondents obtained the following quote: "Tabeke et al. (J. Agric. Food Chem., 2002, 50: 4998-5006) reported that acrylamide is formed during heating of starch-rich foods to high temperatures. The acrylamide formation has been ascribed to the Maillard reaction (Mottram et al. and Stadtler et al., 2002, Nature 419: 448-449)."
"We are very proud to receive this award. It is a recognition for all employees of ERYTECH and our many partners, without whom we would not have come to this stage. All of us share one mission: to develop innovative tumor starvation treatments for cancer patients, particularly those with acute leukemia and selected solid tumors . " said Pierre-Olivier Goineau, COO and co-founder of ERYTECH together with Yann Godfrin, inventor of the technology
"We are very pleased and encouraged by the positive results of this Phase III study. They validate the potential of our red cell bioreactor technology platform to increase the therapeutic index and tolerability of certain drugs. With GRASPA™, the enzyme activity is protected by the red cell membrane, preventing neutralisation by circulating antibodies. I wish to take this opportunity to thank all people who contributed to this study, patients, physicians and the Erytech team and collaborators, for their efforts and dedication." , said Yann Godfrin, co-founder and Chief Scientific Officer of ERYTECH Pharma

Mer innehåll

Alla (27) | Nyheter (23) | Rapporter (0) | Bloggar (2) | Ljud/Video (0) | Faktablad (0) | Pressreleaser (2)
sort by: Date | Relevance
Destructive Ulcerated Lesions of the Hard Palate [Published New England Journal of Medicine - Oct 23 2014]
Erytech Secures New Patent in the United States [Published Individual.com - Oct 23 2014]
ERYTECH PHARMA : Secures Patent [Published 4 Traders - Oct 23 2014]
NOVOZYMES A/S : Patent Issued for Method of Pre... [Published 4 Traders - Oct 23 2014]
Jazz Pharmaceuticals to Report 2014 Third Quart... [Published Pettinga Financial Advisors - Oct 21 2014]
ERYTECH PHARMA : wins EuropaBio’s Most Innovati... [Published 4 Traders - Oct 21 2014]
DGAP-News: ERYTECH PHARMA SA: ERYTECH announces... [Published GlobeNewswire: Acquisitions News - Oct 21 2014]
BRIEF-Erytech Pharma gets new patent in U.S. in... [Published Reuters UK - Oct 20 2014]
ERYtech Pharma Announces Granting Of New Patent... [Published BioSpace - Oct 20 2014]
ERYTECH Announces Granting of New Patent in the... [Published Business Wire Health News - Oct 20 2014]
ERYTECH wins EuropaBio's Most Innovative Europe... [Published Scottrade - Oct 09 2014]
Test for predicting neutralization of asparagin... [Published Free Patents Online - Oct 07 2014]
Karolinska Development's CEO leaves, Erytech hi... [Published FierceBiotech - Oct 02 2014]
Erytech reports positive Phase III results from... [Published Pharma Letter - Oct 01 2014]
ERYTECH Reports Positive Top-Line Phase III Res... [Published BusinessWeek - Sep 30 2014]
Understanding Digestive Enzymes [Published FoodProcessing.com - Sep 22 2014]
Long live peptides evolution of peptide half-li... [Published Drug Discovery World - Sep 15 2014]
Caring for a Child With Leukemia [Published Parents.com - Sep 15 2014]
ERYTECH Announces Second Positive DSMB Review o... [Published Pharmacy Choice - Sep 15 2014]
MicroRNA-140-5p as a tumor suppressor and sensi... [Published PharmCast - Jul 18 2014]
Research and Markets: Baking Enzymes Market 201... [Published Business Wire Retail News - May 20 2014]
Compositions and methods for delivering inhibit... [Published PharmCast - May 08 2014]
Erytech receives ANSM authorisation to begin ph... [Published PharmaBiz - May 07 2014]
Tumor-initiating cells and methods of use [Published PharmCast - Apr 09 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
1
I fokus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Nyhetsvolym
Document Volume
Nätverk
Network

Bloggar

sort by: Date | Relevance
ERYTECH Announces Granting of New Patent in the... [Published Business Wire Health News - Oct 20 2014]
Research and Markets: Baking Enzymes Market 201... [Published Business Wire Retail News - May 20 2014]
1

Pressreleaser

sort by: Date | Relevance
DGAP-News: ERYTECH PHARMA SA: ERYTECH announces... [Published GlobeNewswire: Acquisitions News - Oct 21 2014]
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.